PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. - Kristeleit R; Leary A; Oaknin A; Redondo A; George A; Chui S; Seiller A; Liste-Hermoso M; Willis J; Shemesh CS; Xiao J; Lin KK; et al. (British journal of cancer, 2024)